HUP0003476A3 - Method for preventing the oral misuse of a transdermal therapeutic system and a trasdermal therapeutic system containing denaturing agent - Google Patents

Method for preventing the oral misuse of a transdermal therapeutic system and a trasdermal therapeutic system containing denaturing agent

Info

Publication number
HUP0003476A3
HUP0003476A3 HU0003476A HUP0003476A HUP0003476A3 HU P0003476 A3 HUP0003476 A3 HU P0003476A3 HU 0003476 A HU0003476 A HU 0003476A HU P0003476 A HUP0003476 A HU P0003476A HU P0003476 A3 HUP0003476 A3 HU P0003476A3
Authority
HU
Hungary
Prior art keywords
therapeutic system
trasdermal
misuse
oral
preventing
Prior art date
Application number
HU0003476A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of HUP0003476A2 publication Critical patent/HUP0003476A2/hu
Publication of HUP0003476A3 publication Critical patent/HUP0003476A3/hu
Publication of HU226644B1 publication Critical patent/HU226644B1/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Saccharide Compounds (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
HU0003476A 1997-10-01 1998-09-18 Trasdermal therapeutic system for protecting a person from taking in its poisoning components via oral misuse HU226644B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19743484A DE19743484C1 (de) 1997-10-01 1997-10-01 Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems
PCT/EP1998/005955 WO1999016428A1 (de) 1997-10-01 1998-09-18 Verfahren zur vermeidung des missbrauchs eines transdermalen therapeutischen systems

Publications (3)

Publication Number Publication Date
HUP0003476A2 HUP0003476A2 (hu) 2001-02-28
HUP0003476A3 true HUP0003476A3 (en) 2001-04-28
HU226644B1 HU226644B1 (en) 2009-05-28

Family

ID=7844345

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003476A HU226644B1 (en) 1997-10-01 1998-09-18 Trasdermal therapeutic system for protecting a person from taking in its poisoning components via oral misuse

Country Status (23)

Country Link
EP (1) EP1019032B1 (hu)
JP (2) JP4755338B2 (hu)
KR (1) KR100552102B1 (hu)
AT (1) ATE228356T1 (hu)
AU (1) AU759609B2 (hu)
CA (1) CA2305432C (hu)
DE (2) DE19743484C1 (hu)
DK (1) DK1019032T3 (hu)
ES (1) ES2188021T3 (hu)
HK (1) HK1029919A1 (hu)
HU (1) HU226644B1 (hu)
ID (1) ID24333A (hu)
IL (1) IL134479A (hu)
MY (1) MY116425A (hu)
NO (2) NO319163B1 (hu)
NZ (1) NZ503643A (hu)
PL (1) PL193066B1 (hu)
PT (1) PT1019032E (hu)
SK (1) SK3332000A3 (hu)
TR (1) TR200000461T2 (hu)
TW (1) TW431894B (hu)
WO (1) WO1999016428A1 (hu)
ZA (1) ZA988904B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19743484C1 (de) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
DE102004019916A1 (de) * 2004-04-21 2005-11-17 Grünenthal GmbH Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
CN112823191A (zh) * 2018-10-17 2021-05-18 日荣新化株式会社 粘合片及其制造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
DE4342174C1 (de) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
DE19743484C1 (de) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems

Also Published As

Publication number Publication date
WO1999016428A1 (de) 1999-04-08
NO20001691D0 (no) 2000-03-31
PL193066B1 (pl) 2007-01-31
ES2188021T3 (es) 2003-06-16
HUP0003476A2 (hu) 2001-02-28
ID24333A (id) 2000-07-13
NO20001492D0 (no) 2000-03-22
ATE228356T1 (de) 2002-12-15
CA2305432A1 (en) 1999-04-08
NO20001691L (no) 2000-03-31
ZA988904B (en) 1999-04-12
JP4755338B2 (ja) 2011-08-24
PT1019032E (pt) 2003-04-30
CA2305432C (en) 2007-04-03
KR100552102B1 (ko) 2006-02-13
DK1019032T3 (da) 2003-03-10
SK3332000A3 (en) 2000-11-07
AU9626598A (en) 1999-04-23
DE19743484C1 (de) 1999-01-28
HK1029919A1 (en) 2001-04-20
PL339736A1 (en) 2001-01-02
DE59806468D1 (de) 2003-01-09
EP1019032A1 (de) 2000-07-19
MY116425A (en) 2004-01-31
KR20010030886A (ko) 2001-04-16
HU226644B1 (en) 2009-05-28
IL134479A (en) 2005-07-25
AU759609B2 (en) 2003-04-17
TW431894B (en) 2001-05-01
NO319163B1 (no) 2005-06-27
NO20001492L (no) 2000-03-22
NZ503643A (en) 2003-05-30
JP2009035561A (ja) 2009-02-19
TR200000461T2 (tr) 2000-09-21
EP1019032B1 (de) 2002-11-27
JP2001517695A (ja) 2001-10-09
IL134479A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
HK1029914A1 (en) Device and pharmaceutical agent for treatment of dysmenorrhea
AU1805499A (en) Method and apparatus for delivery of therapeutic agents to the heart
AU5343899A (en) Catheter drug delivery system and method for use
AU8658498A (en) Delivery of agents and method for regeneration of periodontal tissues
AU9040098A (en) Compounds and method for the prevention and treatment of diabetic retinopathy
IL127189A0 (en) Compositions methods and devices for the transdermal delivery of drugs
EP0956091A4 (en) APPARATUS FOR DELIVERY OF IONTOPHORETIC DRUGS, AND METHOD OF USE
AU1765400A (en) Apparatus and method for relating pain and activity of a patient
AU1970495A (en) Drug delivery device and method of construction
PL320952A1 (en) Cycloalkanon pyridines, method of obtaining and therapeutic agents containing them
PL317930A1 (en) Oxalydine compounds, method of obtaining them and therapeutic agents
GB9701904D0 (en) A system for the delivery of drugs and therapeutic agents
EP1036573A4 (en) DEVICE FOR ADMINISTERING A SUBSTANCE THROUGH THE SKIN OR A MUCUTINE
EP0941039A4 (en) TRANSDERMAL ADMINISTRATION OF 7alpha-METHYL-19-NORTESTOSTERONE ("MENT")
ZA200007751B (en) Transdermal therapeutic system containing hormones and chrystallization inhibitors.
GB2330091B (en) Method and means for coating medical cannulas
IL211081A0 (en) Methods and devices for providing prolonged drug therapy
AU7277598A (en) Energy delivery of catheter and method for the use thereof
ZA9670B (en) Composition and methods for transdermal delivery of acid-lability drugs
HUP9801130A3 (en) Transdermal therapeutic system for administering testosterone
ZA954118B (en) Transdermal delivery of anti-epileptic drugs
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
HUP0003476A3 (en) Method for preventing the oral misuse of a transdermal therapeutic system and a trasdermal therapeutic system containing denaturing agent
EP0921803A4 (en) METHOD FOR PREVENTING AND TREATING PESTVIRUS INFECTIONS AND RELATED DISEASES
EP0776200A4 (en) AGENT AND METHOD FOR PROTECTING DRUG ADDICTION

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees